Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the ASCP and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie
- Delivery of Care
- Schizophrenia/ Schizoaffective Disorders
- AMA PRA Category 1 Credit™
The quantification of antipsychotic levels in blood, or therapeutic drug monitoring (TDM), could aid clinicians in numerous challenging scenarios. Learn more about using TDM for dosing decisions in this journal CME activity that describes expert consensus.